pubmed-article:11504980 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C0085090 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C0887947 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
pubmed-article:11504980 | lifeskim:mentions | umls-concept:C2003874 | lld:lifeskim |
pubmed-article:11504980 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:11504980 | pubmed:dateCreated | 2001-8-15 | lld:pubmed |
pubmed-article:11504980 | pubmed:abstractText | To evaluate the impact of response to highly active antiretroviral therapy (HAART) on the natural history of AIDS non-Hodgkin's lymphoma (NHL) and to analyse the feasibility, efficacy and toxicity of HAART in combination with chemotherapy. | lld:pubmed |
pubmed-article:11504980 | pubmed:language | eng | lld:pubmed |
pubmed-article:11504980 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11504980 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11504980 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11504980 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11504980 | pubmed:month | Aug | lld:pubmed |
pubmed-article:11504980 | pubmed:issn | 0269-9370 | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:RucoLL | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:IppolitiAA | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:PalmieriFF | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:CaudaRR | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:De LucaAA | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:SerrainoDD | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:AntinoriAA | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:AmmassariAA | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:LaroccaL MLM | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:AlbaLL | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:CingolaniAA | lld:pubmed |
pubmed-article:11504980 | pubmed:author | pubmed-author:CiancioB CBC | lld:pubmed |
pubmed-article:11504980 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11504980 | pubmed:day | 17 | lld:pubmed |
pubmed-article:11504980 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:11504980 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11504980 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11504980 | pubmed:pagination | 1483-91 | lld:pubmed |
pubmed-article:11504980 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:meshHeading | pubmed-meshheading:11504980... | lld:pubmed |
pubmed-article:11504980 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11504980 | pubmed:articleTitle | Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. | lld:pubmed |
pubmed-article:11504980 | pubmed:affiliation | National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy. antinori@inmi.it | lld:pubmed |
pubmed-article:11504980 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11504980 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11504980 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11504980 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11504980 | lld:pubmed |